Rare diseases
Investigational molecules
Locations
Zerotinovo Namesti 617/9, Brno-Mesto, 602 00 Brno, Czechia
Psychoses and autism spectrum disorder are central areas of interest, with attention to biological factors linked to treatment response and core symptom expression.
Research activity in this domain includes pharmacogenetic and microbiome-related approaches to psychiatric symptoms and neurodevelopmental phenotypes.
Masarykova Univerzita runs clinical trials in conditions such as Infantile apnoea, Autism spectrum disorder, Chronic myeloid leukaemia (in remission), Epidermolysis bullosa, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Testing Caffeine Citrate for Reducing Breathing Support Needs in Premature Newborns with Primary Apnea
CzechiaA study to evaluate the effect of allogeneic faecal microbiota on the core symptoms of autism spectrum disorder in children
CzechiaStudy on Stopping Nilotinib, Imatinib, and Dasatinib in Patients with Chronic Myeloid Leukemia in Deep Remission
CzechiaStudy on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells for Patients with Epidermolysis Bullosa
CzechiaStudy on Murcidencel for Children, Adolescents, and Young Adults with High-Risk Progressive or Recurrent Metastatic Tumors
CzechiaStudy on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
